Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Megestrol acetate helps fat-derived stem cells grow, move, and turn into fat cells through a specific receptor.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

The document suggests using trazodone and clomiphene to treat sexual dysfunction caused by post-finasteride syndrome.

Combination therapy significantly reduces testosterone and moderately reduces hair growth in women with hirsutism.

TPA is about 50 times more effective at promoting tumors than MZ.

Increasing TSPO in the brain reduces anxiety and depression.

Cyproterone acetate effectively treats hirsutism and related conditions.

Agmatine may help reduce seizures linked to hormone changes in female rats.

A new compound was effective for imaging prostate cancer in rats.

The treatment successfully lowered testosterone levels and reduced symptoms.

Finasteride may affect fetal brain development and increase arousal, but more research is needed for safety confirmation.

Ovarian and stress hormones can change GABA A receptors through neurosteroids.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

A new method was developed to make finasteride for treating hair loss.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Researchers developed a quick and accurate method to measure hormones in urine, confirming a baldness treatment's effectiveness without altering hormone levels.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Using 5-butylpicolinate esters improves the sensitivity and reliability of detecting testosterone and dihydrotestosterone in saliva.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Researchers developed a reliable way to measure hormones in urine, showing that a baldness treatment doesn't change hormone levels.

A woman developed male characteristics after using unregulated hormone therapy.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

CE-PTG detects early hair follicle issues in balding areas, helping measure male hair loss.

SHPro® improved urinary symptoms and erectile function in men and is safe.

Estrogens can reduce DHT production in hair follicles, but are less effective than finasteride and progesterone.